The authors are affiliated with one or more of the following institutions: Baylor College of Medicine, Baylor-St
Lillys drugs, Mounjaro and Zepbound, are dual-agonists that target GIP and GLP-1, while Novo Nordisks Wegovy is a single GLP-1 agonist
BECKER: So Daniel Gilbert, when we hear that response from Novo Nordisk saying, "It's not us, it's the U.S
J Biol Chem 294:48434853 Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants
Z-VAD-FMK can be used for the study of acute pancreatitis
Medicare will cover GLP-1s for a BMI of 35 or more, or a BMI of 27 or more with some qualifying conditions: The prescription must be for weight reduction and weight maintenance in combination with lifestyle modification (structured nutrition and physical activity)